Hypoglycemic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice

被引：0
|
作者：
Inoue, T
Yoshitomi, H
Kasai, S
Hihara, T
Matsuura, F
Shinoda, M
Saeki, T
Tanaka, I
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A129 / A129
页数：1
相关论文
共 50 条
  • [31] RECENT ADVANCES ON NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AND GAMMA AGONISTS
    Toma, Alemayehu
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (05): : 1644 - 1653
  • [32] Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects
    Berger, J
    Leibowitz, MD
    Doebber, TW
    Elbrecht, A
    Zhang, B
    Zhou, GC
    Biswas, C
    Cullinan, CA
    Hayes, NS
    Li, Y
    Tanen, M
    Ventre, J
    Wu, MS
    Berger, GD
    Mosley, R
    Marquis, R
    Santini, C
    Sahoo, SP
    Tolman, RL
    Smith, RG
    Moller, DE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) : 6718 - 6725
  • [33] Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ)-specific agonist, as a modulator in experimental acute pancreatitis
    Celinski, Krzysztof
    Madro, Agnieszka
    Prozorow-Krol, Beata
    Korolczuk, Agnieszka
    Cichoz-Lach, Halina
    Slomka, Maria
    Korobowicz, Elzbieta
    MEDICAL SCIENCE MONITOR, 2009, 15 (01): : BR21 - BR29
  • [34] Effects of Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat
    Suzuki, Shugo
    Arnold, Lora L.
    Pennington, Karen L.
    Kakiuchi-Kiyota, Satoko
    Wei, Min
    Wanibuchi, Hideki
    Cohen, Samuel M.
    TOXICOLOGICAL SCIENCES, 2010, 113 (02) : 349 - 357
  • [35] Bidirectional fluorescence properties of pyrene-based peroxisome proliferator-activated receptor (PPAR) α/δ dual agonist
    Ban, Shintaro
    Oyama, Takuji
    Kasuga, Jun-ichi
    Ohgane, Kenji
    Nishio, Yoshino
    Morikawa, Kosuke
    Hashimoto, Yuichi
    Miyachi, Hiroyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (11) : 3460 - 3464
  • [36] Evidence for peroxisome proliferator-activated receptor (PPAR)α-independent peroxisome proliferation:: Effects of PPARγ/δ-specific agonists in PPARα-Null mice
    DeLuca, JG
    Doebber, TW
    Kelly, LJ
    Kemp, RK
    Molon-Noblot, S
    Sahoo, SP
    Ventre, J
    Wu, MS
    Peters, JM
    Gonzalez, FJ
    Moller, DE
    MOLECULAR PHARMACOLOGY, 2000, 58 (03) : 470 - 476
  • [37] Determination of chiglitazar, a dual alpha/gamma peroxisome proliferator-activated receptor (PPAR) agonist, in human plasma by liquid chromatography-tandem mass spectrometry
    Chu, N. N.
    Li, X. N.
    Chen, L.
    Xu, H. R.
    PHARMAZIE, 2007, 62 (11): : 825 - 829
  • [38] Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARγ) in human neuroblastoma cells
    Han, SW
    Greene, ME
    Pitts, J
    Wada, RK
    Sidell, N
    CLINICAL CANCER RESEARCH, 2001, 7 (01) : 98 - 104
  • [39] Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: A rat model
    Mahal, Amandeep
    Young-Lin, Nichole
    Dobberfuhl, Amy
    Estes, Jaclyn
    Comiter, Craig Vance
    INVESTIGATIVE AND CLINICAL UROLOGY, 2018, 59 (04) : 257 - 262
  • [40] Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystiytis: a rat model
    Comiter, Craig
    Mahal, Amandeep
    Dobberfuhl, Amy
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S142 - S143
12345